Challenges, Progress, and Opportunities: Proceedings of the Filovirus Medical Countermeasures Workshop

Viruses

Rona Hirschberg³  Lucy A. Ward³  Nicole Kilgore⁴  Rebecca Kurnat⁴  Helen Schiltz³  Mark T. Albrecht¹  George W. Christopher² 

[1]Biodefense Advanced Research and Development Authority, Assistant Secretary for Preparedness and Response, Department of Health and Human Services, Washington, DC 20201, USA

[2] E-Mail:

[3]Medical Countermeasure Systems, Department of Defense, Fort Belvoir, VA 22060, USA

[4] E-Mail:

[5]Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA

[6] E-Mails:

[7]Medical Countermeasure Systems, Department of Defense, Ft. Detrick, Frederick, MD 21702, USA

[8] E-Mails:

关键词: Ebola;    Sudan;    ebolavirus;    Marburg virus;    marburgvirus;    Filoviridae;    filovirus medical countermeasures;    Filovirus Animal Non-clinical Group;    FANG;   

DOI  :  10.3390/v6072673

来源: mdpi

【 摘 要 】

On August 22–23, 2013, agencies within the United States Department of Defense (DoD) and the Department of Health and Human Services (HHS) sponsored the Filovirus Medical Countermeasures (MCMs) Workshop as an extension of the activities of the Filovirus Animal Non-clinical Group (FANG). The FANG is a federally-recognized multi-Agency group established in 2011 to coordinate and facilitate U.S. government (USG) efforts to develop filovirus MCMs. The workshop brought together government, academic and industry experts to consider the needs for filovirus MCMs and evaluate the status of the product development pipeline. This report summarizes speaker presentations and highlights progress and challenges remaining in the field.

【 授权许可】

CC BY   
© 2014 by the authors; licensee MDPI, Basel, Switzerland.